发明名称 Chromone enteric release formulation
摘要 Orally administered chromones have been found to be effective in the treatment of allergic conditions such as asthma, general food allergies, ulcerative colitis, atopic eczema, chronic urticaria, and irritable bowel syndrome if it is presented such that the respective chromone becomes bioavailable within ten minutes of exposure to an intestinal fluid.
申请公布号 US7258872(B1) 申请公布日期 2007.08.21
申请号 US19990831681 申请日期 1999.11.09
申请人 THORNTON & ROSS LIMITED 发明人 WIGMORE ALEXANDER JAMES
分类号 A61K9/20;C07D311/22;A61K9/16;A61K9/22;A61K9/26;A61K9/28;A61K9/30;A61K9/48;A61K9/50;A61K31/352;A61K45/00;A61K47/14;A61K47/38;A61P1/00;A61P1/06;A61P1/08;A61P9/00;A61P11/00;A61P11/06;A61P17/00;A61P25/06;A61P27/16;A61P37/00;A61P37/08 主分类号 A61K9/20
代理机构 代理人
主权项
地址